degrades unfolded proteins by 26S proteasome and through autophagy, the process called as ER-associated degradation (ERAD). If these adaptations fail to keep cell homeostasis, the UPR 4) commits the cell to a pathway of apoptosis or dedifferentiation (3) .
Chronic UPRs are causally linked to the pathogenesis of human metabolic diseases such as obesity and type 2 diabetes. Accumulating evidence suggests that obesity promotes ER stress, which is detected as an enhanced UPR signaling, that activates c-jun N terminal kinase (JNK) and impairs insulin signaling at the level of IRSs in the liver and adipose tissue (4) (Figure) . However, it still remains unknown what signals activate UPR under this condition.
Defective autophagy (5) and proteasome dysfunction (6) have recently been proposed as molecular links between obesity and ER stress (Figure) . In obesity scenario, ER stress in the liver and adipose tissue is assumed to cause insulin resistance and associated hyperinsulinemia (Figure) . Conversely, it is possible to assume that hyperinsulinemia comorbid in obesity causes ER stress. Indeed, previous in vitro studies suggest that insulin upregulates UPR markers in cultured murine peritoneal macrophages (7) and human neuroblastoma cells (8) .
In this issue of Diabetes (9) Interestingly, insulin-induced accumulation of the ubiquitinated proteins in the adipose tissue seems marginal and variable in their study. This suggests that, beside unfolded protein accumulation, other pathways directly altering ER homeostasis also should be taken into account. These pathways may also be candidate pathologic conditions mediating ER stress in obesity, and may involve oxidative stress (10), hypoxia (11) and toxic lipid (12) .
To completely exclude involvement of glucose uptake in the insulin-induced ER stress, it should be confirmed that glucose transport inhibitors do not cancel the insulin-induced ER stress in 3T3-L1 adipocytes.
If the insulin-mediated UPR is dependent on enhanced protein biosynthesis, accumulation of ubiquitinated protein precedes the onset of UPR in the 3T3-L1 adipocytes cultured with insulin. Also, the insulin-induced ER stress must be canceled with protein biosynthesis inhibitors. In addition to enhanced protein biosynthesis, autophagy (5) and proteasome (6) are candidate targets of insulin to induce ER stress, because insulin impairs their function as observed in the state of obesity (Figure) .
Concerning the significance of the present findings in the cellular and body homeostasis, Boden et al. postulate that insulin-induced UPR may relieve the ER stress and its associated insulin resistance. On the other hand, they pay caution to unrelieved ER stress and insulin resistance caused by long-lasting hyperinsulinemia owing to excessive calorie intake or in diabetic patients treated with high-dose insulin (Figure) . An important issue that should be proved is the net effects of insulin on the balance between UPR-mediated relief of ER stress and UPR-induced insulin resistance. Evaluation of some signs of UPR-induced insulin resistance, for example, JNK activation and decreased levels of insulin receptor substrates (6), might help understanding which direction the UPR remodels a cell toward either recovery or illness.
Finally, insulin is one of the key players in accelerating aging (13) . In this regard, it would be possible to assume that insulin resistance itself can be a compensatory adaptation to avoid cellular aging caused by excessive insulin 
